JOURNAL OF CARDIOVASCULAR SURGERY心血管外科杂志
JOURNAL OF CARDIOVASCULAR SURGERY(英文缩写 J CARDIOVASC SURG),ISSN 0021-9509,eISSN 1827-191X,中文译名:心血管外科杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-28 至 2026-09-28，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 1.595 | Q4 |
| 2022 | 1.400 | Q3 |
| 2023 | 1.400 | Q3 |
| 2024 | 1.500 | Q3 |
| 2025 | 1.300 | Q3 |
JOURNAL OF CARDIOVASCULAR SURGERY 最新收录文献
-
1. Impact of Body Mass Index on outcomes of abdominal aortic aneurysm repair: a systematic review and meta-analysis.
PMID:日期:2026-09-16The influence of Body Mass Index (BMI) on outcomes after abdominal aortic aneurysm (AAA) repair remains controversial. While the 'obesity paradox' is generally noted for other cardiovascular diseases, evidence from vascular surgery is limited. This systematic review evaluated the impact of BMI on mortality and postoperative complications following AAA repair. The databases of PubMed, Embase, Scopus, and Web of Science were explored up to 13 October 2025 for studies comparing outcomes across BMI categories in adults undergoing open or endovascular AAA repair. Random-effects meta-analyses were conducted. Sensitivity analyses, subgroup analyses by surgical approach and follow-up duration, and Egger's test for publication bias were performed. Twelve retrospective cohort studies were included. Mortality meta-analysis demonstrated a J-shaped association between BMI and mortality risk: overweight and obese patients had lower mortality than normal-weight individuals, while underweight patients exhibited higher mortality. Sensitivity analyses mostly confirmed the robustness of findings. Subgroup analyses revealed variable effects across open and endovascular repair, as well as different follow-up durations. Egger's test revealed no evidence of publication bias. Secondary outcome analysis showed comparable rates of most perioperative complications across BMI groups, with lower cardiac events among overweight and obese patients. The present evidence suggests that a higher BMI may not be associated with increased mortality risk and appears to confer a survival benefit after AAA repair, whereas underweight status predicts poorer survival outcomes. The risk of other complications does not appear to differ across BMI groups.
-
2. Chimney performance in complex abdominal aortic aneurysms compared to fenestrated endovascular aortic repair.
PMID:日期:2026-09-08The chimney technique may offer an alternative approach for managing juxta- and pararenal abdominal aortic aneurysms (AAA). This analysis presents the outcomes of the chimney technique and compares elective chimney and fenestrated endovascular aortic repair (FEVAR) findings in complex AAA. The STROBE statement was followed to conduct a single-center retrospective analysis of patients who underwent chimney for complex AAA from January 1, 2016, to December 31, 2024. A comparison between elective chimney and FEVAR cases was also performed. Primary outcomes included technical success, mortality and survival. Seventy-two patients underwent chimney (94.4% males); 60 elective cases. Regarding the total chimney cohort, technical success was 98.6% and 30-day mortality 11.1%. Gutter endoleaks were detected in 6.9%; all resolved at 30 days. The mean follow-up was 36.8±5.8 months. Survival was 48.2% (standard error [SE] 9.5%) and freedom from reintervention was 87.3% (SE 6.5%) at 60 months. Forty-one elective FEVARs were compared to 60 elective chimney cases. Elective chimney patients had significantly larger aortic diameters (63 [Q1:56, Q3:78] mm vs. 56 [Q1:54, Q3:66] mm, P=0.02). Technical success (P=0.79) and 30-day mortality (P=0.30) were similar. The mean follow-up in elective chimney was longer compared to FEVAR (40.0±6.3 vs. 27.5±6.3 months; P=0.03). The estimated survival was consistently significantly lower in elective chimney cases (log rank; P=0.003) while freedom from reintervention was similar (P=0.88). The chimney technique demonstrated acceptable 30-day outcomes. Compared to elective chimney, 30-day FEVAR outcomes were similar, but FEVAR survival was significantly higher. The need for reintervention was equal.
-
3. Shared decision-making in patients with abdominal aortic aneurysm and peripheral arterial disease: a qualitative study.
PMID:日期:2026-09-08The aim of this study was to gain insight in how patients with an abdominal aortic aneurysm (AAA) or peripheral arterial disease (PAD) experience shared decision-making (SDM) and to examine the role of health literacy (HL), specifically the domain of knowledge and information provision. An original qualitative descriptive study was conducted using the principles of reflexive thematic analysis. Semi-structured interviews were conducted with purposively sampled vascular surgery patients from the University Medical Center Groningen and Ommelander Hospital Groningen between March and September 2024. Data collection and analysis followed an iterative approach, with interviews audio-recorded, transcribed, and analyzed inductively. Health literacy (Brief Health Literacy Screener), frailty (Groningen Frailty Indicator), and cognition (Mini-Cog) were assessed to contextualize findings. Data saturation was reached when no new insights emerged. Descriptive statistics were used for quantitative measures. Data saturation was reached after conducting 11 interviews. Four themes emerged regarding SDM and HL disease knowledge and information provision: 1) the decision; 2) desires, goals, and concerns; 3) information; and 4) disease knowledge. While some patients perceived active participation, most felt minimally involved, partly because their goals and concerns were not actively addressed by the treating physician. Patients generally regarded the vascular surgeon as their primary source of information. Knowledge levels and information needs varied between the included patients, influencing patient engagement in SDM. In this qualitative study, patients with AAA or PAD generally felt minimally involved in decision-making and often assumed that their vascular surgeon was unaware of their personal goals. Disease knowledge was typically limited, likely hindering patient participation in SDM.
-
4. Rationale and design of a prospective European multicenter evaluation of the iCover balloon-expandable covered stent as a bridging stent in fenestrated endovascular aortic repair (fenCo).
PMID:日期:2026-08-03Fenestrated endovascular aortic repair (FEVAR) is an established treatment for complex abdominal aortic aneurysms involving the renovisceral segment. Long-term durability remains dependent on bridging stent performance, yet prospective device-specific data remain limited. The fenCo study was designed to evaluate the clinical performance and safety of the iCover balloon-expandable covered stent (iVascular) used as a bridging stent during FEVAR. fenCo is a prospective, multicenter, open-label, single-arm European clinical investigation conducted in 24 high-volume centers under Regulation (EU) 2017/745. The study aims to include 165 patients undergoing FEVAR for juxtarenal, pararenal, suprarenal, or thoracoabdominal aneurysms using an IFU-compliant fenestrated endograft. All target vessels are bridged exclusively using the iCover balloon-expandable covered stent. Follow-up is planned at discharge, 6 months, and 12 months, with optional extension to 5 years. The primary efficacy endpoint is bridging-stent patency at 12 months, defined as absence of binary restenosis (≥50% stenosis) or occlusion on imaging. The primary safety endpoint is freedom from target vessel instability, defined as a composite of aneurysm rupture, target vessel occlusion, component separation, branch-related endoleak, or branch-related reintervention. Secondary endpoints include technical success, endoleaks, reinterventions, mortality, aneurysm sac evolution, and renal outcomes. fenCo will provide prospective multicenter European data on the safety and performance of the iCover stent used as a bridging stent during FEVAR using predefined imaging-based and clinically adjudicated endpoints. The study is expected to strengthen the evidence base for bridging stent selection in complex endovascular aortic repair.
-
5. Preliminary experience with the low profile VBX as bridging stent-graft in fenestrated and branched endovascular aortic repair.
PMID:日期:2026-08-01Fenestrated and branched endovascular repair (F/B-EVAR) for thoracoabdominal (TAAA) and juxta/pararenal (J/P-AAA) aortic aneurysms has shown good mid- and long-term outcomes; however, the bridging stent graft (BSG) choice remains debated. A new low-profile BSG, The GORE VIABAHN VBX Balloon Expandable (BX) was introduced in December 2024. The aim was to report the BX preliminary outcomes in F/B-EVAR. Consecutive patients treated with at least 1 BX in F/B-EVAR between January and August 2025 were retrospectively analyzed. Early outcomes (30 days/in-hospital) included technical and clinical success, patency, and target vessel instability (TVI). Six-month outcomes included secondary endoleak, patency, and TVI, according to the Society for Vascular Surgery (SVS) reporting standards. A total of 180 target vessels (TVs) in 47 patients were analyzed. Procedures included 17 preloaded-FEVAR, 11 off-the-shelf T-branch, 11 custom-made (CM) BEVAR, and 8 CM-F/B-EVAR. Indications included: 20 TAAA, 19 J/P-AAA, and 8 type IA endoleaks in EVAR. Median aneurysm diameter was 60 mm (53-66). Technical success was achieved in 99.4% (179/180 TVs), with 100% assisted technical success. Clinical success was 89.4% (42/47 patients), all BX-unrelated. Thirty-day TVI was 0.5%, with one renal branch occlusion successfully treated, leading to a secondary patency of 100%. At 6-months, 46 patients completed imaging. One renal fenestration type IC endoleak and one additional renal branch occlusion were observed. Overall primary and secondary patency were 98.9% and 99.4%, respectively. TVI was 1.7%. The BX stent-graft appears safe and effective in F/B-EVAR, with satisfying preliminary results. Larger studies with longer follow-up are required to confirm BX durability.
-
6. Real world one-year outcomes of the GORE® VIABAHN® balloon-expandable endoprosthesis in FEVAR and BEVAR: insights from the EXPAND and EMBRACE registries.
PMID:日期:2026-08-01The aim of this study was to evaluate one-year clinical performance and safety of the GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) used as a bridging stent in fenestrated and branched endovascular aortic repair (FEVAR and BEVAR). This narrative review summarizes one-year outcomes from two multicenter European registries, EXPAND and EMBRACE. Outcomes are presented separately for FEVAR and BEVAR cohorts within each study, without statistical pooling or cross-study comparison. Endpoints assessed included target vessel (TV) technical success, primary patency, target-vessel instability (TVI), freedom from reintervention, and survival at one year. EXPAND included 39 FEVAR patients (97 TVs) and 73 BEVAR patients (223 TVs), and EMBRACE included 103 FEVAR patients (208 TVs) and 165 BEVAR patients (454 TVs). Technical success was 100% for both FEVAR cohorts and reached 100% and 99.6% in the EXPAND and EMBRACE BEVAR cohorts, respectively. At one year, TV primary patency in FEVAR was 100% (EXPAND) and 99.4% (EMBRACE), while BEVAR patency was 94.9% (EXPAND) and 98.9% (EMBRACE). Freedom from TVI was 100% and 96.6% in FEVAR and 97% and 94.5% in BEVAR (EXPAND and EMBRACE, respectively). Patient-level freedom from reintervention remained high across FEVAR (100% EXPAND, 94.8% EMBRACE) and BEVAR (92.6% EXPAND, 91.7% EMBRACE). All TV reinterventions were managed endovascularly. One-year survival was higher in FEVAR (94.9% EXPAND, 94.1% EMBRACE) than in BEVAR (86.2% EXPAND, 79.2% EMBRACE). The VBX stent graft is an effective bridging stent, with near-perfect technical success and excellent one-year TV patency in FEVAR and BEVAR. BEVAR showed higher reintervention rates that remained low and manageable with percutaneous secondary procedures.
-
7. Midterm outcomes of VBX bridging stent grafts in complex branched endovascular aortic repair.
PMID:日期:2026-08-01The aim of the study was to evaluate the midterm durability of GORE VIABAHN VBX balloon-expandable covered stent grafts used as bridging stents during branched endovascular aortic repair (FB-EVAR), focusing on primary patency and target vessel instability (TVI). This retrospective two-center cohort study analyzed prospectively collected data included consecutive patients undergoing B-EVAR with VBX bridging stent grafts from 2017 to 2025 using company-manufactured devices (CMD). Outcomes were assessed at both vessel and patient levels. Primary outcomes were target vessel instability (TVI) and primary patency per reporting standards. Secondary outcomes included secondary intervention, endoleak subtype, and acute kidney injury (AKI; RIFLE). Time-to-event outcomes were analyzed using Kaplan-Meier methods. Among 315 patients, 792 target vessels were treated with branch configuration (265 celiac artery (CA), 277 superior mesenteric artery (SMA) with a VBX, and 250 renal arteries (RA) with VBX and Viabahn, while the remainder of the vessels (total of 468), were treated with fenestrations (SMA 20, celiac 25, renals 91) or other stent platforms. Median age was 73 years (interquartile range [IQR] 67-78), and median follow-up was 2.05 years (IQR, 0.79-3.22). Perioperative (30 days) AKI occurred in 2.2% (7/315), with permanent dialysis in 1% (3/315). The cumulative incidence of any secondary intervention per patient was 6.0%, 12.5%, 34.3% at 1, 2, and 3 years. Cumulative incidences of type I, II, and III endoleaks at 3 years were 16.2%, 25.8%, and 8.6%, respectively. Primary patency at 3 years was 96.8% (celiac), 96% (SMA), and 96.8% (renal) (log-rank P=0.47). Vessel-level TVI occurred in 4.4% (35/792), including 2.3% (celiac), 3.6% (SMA), and 7.6% (renal). Patient-level freedom from any TVI was 97.2%, 94.1%, and 85.2% at 1, 2, and 3 years. Freedom from TVI differed by vessel type (3-year: 96.8% celiac, 95.0% SMA, 91.8% renal), with no statistically significant difference across vessel types (log-rank P=0.70). VBX balloon-expandable bridging stent grafts demonstrated durable midterm performance during branched endovascular aortic repair (BEVAR), achieving high patency and low target-vessel instability. Outcomes were consistent with contemporary BEVAR series, supporting VBX as a reliable bridging strategy for complex aortic reconstruction.
-
8. Bench testing of bridging stent-grafts in fenestrated and branched endovascular aortic repair: a scoping review.
PMID:日期:2026-08-01To assess and summarize the available bench and experimental evidence regarding the mechanical performance of bridging stent-grafts (BSGs) used in fenestrated/branched endovascular aortic repair (F/BEVAR). A PRISMA-ScR-guided scoping review was performed using PubMed to identify bench and experimental studies evaluating the mechanical performance of bridging stent-grafts (BSGs) used in F/BEVAR. Eligible studies assessed mechanical characteristics including pull-out resistance, shear resistance, fatigue behavior, geometric deformation, or performance in simulated anatomical models. Extracted data were synthesized descriptively. Seven experimental studies met the inclusion criteria, including in-vitro mechanical evaluations, comparative bench investigations, fatigue testing, and pre-clinical assessment in perfused 3D printed aneurysm models. Findings highlighted device-specific differences in pull-out force, shear stress force, geometric deformation, and fatigue behavior, as well as the influence of implantation configuration on mechanical performance. Bridging stent-grafts demonstrate distinct mechanical characteristics in bench and pre-clinical testing. However, the current evidence remains limited and insufficient to establish device superiority. Standardized testing protocols and further comparative studies are needed.
-
9. Detection of structural failure in bridging stent grafts: photon-counting CT versus dual-energy CT in a controlled in vitro study.
PMID:日期:2026-08-01Bridging stent grafts (BSG) are a critical component of fenestrated and branched endovascular aortic repair (f/bEVAR) but remain prone to structural failure due to continuous biomechanical stress. Early detection of stent wire fractures is clinically relevant, yet remains challenging with conventional computed tomography (CT) because of limited effective spatial resolution and metal-related blooming artifacts. The aim of the study is to evaluate whether photon-counting detector CT (PCCT) improves the detectability of structural defects in BSG compared with dual-energy CT (DECT). An in vitro phantom model incorporating commercially available BSGs with predefined wire fractures was examined using PCCT and DECT across multiple Siemens IQ (dose/resolution) levels. Seven experienced human observers assessed defect visibility using a five-point Likert scale. Interobserver agreement was evaluated using Fleiss' kappa. Quantitative analysis was performed using relative full width at half maximum (FWHM) measurements, expressing defect width relative to stent diameter. PCCT demonstrated markedly superior visibility of stent fractures compared with DECT. Mean Likert scores were 4.66±0.43 for PCCT versus 2.56±0.62 for DECT (median 4.86 vs. 2.43; P<0.001). Ratings indicating good to excellent visibility (Likert 4-5) accounted for 94.7% of PCCT assessments but only 16.9% with DECT. Interobserver agreement was substantially higher for PCCT (κ=0.295) than for DECT (κ=0.004). Quantitative analysis revealed significantly larger relative FWHM values with PCCT (0.72±0.08) compared with DECT (0.60±0.12; P<0.001), consistent across stent types and IQ levels. PCCT achieved stable high detectability already at intermediate IQ levels, whereas DECT showed a gradual dose-dependent improvement. In this controlled experimental setting, PCCT substantially outperformed DECT in the detection of structural bridging stent graft failure, both in subjective and quantitative analyses. These findings suggest that structural BSG defects may be substantially underdetected with conventional CT and that PCCT enables a fundamentally improved level of detectability. This has potential implications for post-f/bEVAR surveillance and warrants further in vivo evaluation.
-
10. Viabahn balloon expandable outcomes as bridging covered stent in fenestrated and branched endovascular aortic repair.
PMID:日期:2026-08-01Target vessel outcomes affect fenestrated and branched endovascular aortic repair (f/bEVAR) durability. This systematic review and meta-analysis aimed to assess Viabahn balloon expandable (VBX) covered stent outcomes for bridging in f/bEVAR. This systematic review was conducted according to PRISMA (PROSPERO: CRD420251034221). Database search was performed in PubMed, Cochrane Library and Embase. Studies between 2017-2025 reporting on f/bEVAR patients managed with bEVAR using the VBX for target vessel bridging were included. The risk of bias was assessed with ROBINS-I and the quality of evidence with GRADE. Target vessel technical success, instability (TVI), occlusion/stenosis, endoleak and reintervention rate were assessed as primary outcomes. Among 1728 studies, 16 were included (2214 patients, 5440 target vessels; 4406 branches, 993 fenestrations; 2918 bridged using VBX). Eight studies were at serious and eight at moderate risk of bias (ROBINS-I). Quality of evidence was 'very low' for all primary outcomes (GRADE). The median follow-up was 12.1 months (95% CI 9.1-15.1). Target vessel technical success was 98.9% (95% CI 97.3-99.5%; I=0%), while TVI was 5.4% (95% CI 3.7-7.6%; I=62%), occlusion/stenosis 3% (95% CI 1.8-4.9%; I=62%), endoleak Ic/IIIc 2.9% (95% CI 2.2-3.7%; I=0) and reintervention rate 3.1% (95% CI 1.6-6.1%; I=54%). Analysis per vessel type revealed higher TVI for renal arteries. Subgroup analysis per incorporation type revealed higher technical success, but worse TVI, occlusion/stenosis and reintervention rate for branches. The VBX demonstrated high technical success and low complication rate. Target vessel incorporation with branches carried higher rates of complications compared to fenestrations.